Tousignant Jennifer 4
4 · Viridian Therapeutics, Inc.\DE · Filed Feb 14, 2024
Insider Transaction Report
Form 4
Tousignant Jennifer
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-12+290,000→ 290,000 totalExercise: $19.68Exp: 2034-02-12→ Common Stock (290,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% on February 12, 2025 and then in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service to Issuer through each vesting date.